正颌手术预防性抗生素预防感染并发症:一项III期、多中心、随机、对照、双盲、两平行组临床试验的研究方案
正颌手术后是否需延长预防性抗生素仍存争议,且缺乏具体指南。本研究为多中心、随机、对照、双盲、两平行组III期临床试验,计划在14个中心、39个月内入组1420例患者,评估不采用术后抗生素预防(AP)在手术部位感染方面是否非劣效于采用AP,主要终点为术后30天内手术部位感染发生率。
要点
- 拟验证正颌手术后不采用抗生素预防在手术部位感染方面非劣效于采用抗生素预防。
- 主要疗效终点为术后30天内手术部位感染发生率,次要终点为术后90天内其他疗效与受试者相关参数。
- 试验计划持续54个月,14个中心在39个月内入组1420例患者。
核心结论
- 研究拟验证正颌手术后不采用抗生素预防在手术部位感染方面非劣效于采用抗生素预防。
研究设计与样本
- 多中心、随机、对照、双盲、两平行组III期临床试验。
- 计划14个中心在39个月内入组1420例患者,整个试验计划持续54个月。
- 主要疗效终点为术后30天内手术部位感染发生率,次要终点为术后90天内其他疗效与受试者相关参数。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It is a constant debate among surgeons whether the use of prolonged postoperative antibiotics may reduce surgical site infection rates. As specific treatment guidelines are still lacking, many surgeons continue to use broad-spectrum antibiotics, causing not only increased costs but also contributing to the potential for antibiotic resistance. Hence, there is an urgent need for an appropriately designed prospective clinical trial, to investigate whether a prophylactic use of antibiotics after surgery actually decreases surgical site infections to a clinically relevant degree. METHODS: This study presents a multicentre, randomised, controlled, double-blinded, clinical trial with two parallel study arms to demonstrate that no postoperative antibiotic prophylaxis (AP) is not inferior to antibiotic prophylaxis with respect to surgical site infections in patients having undergone orthognathic surgery. The primary efficacy endpoint is defined as the occurrence of postoperative surgical site infections within 30 days of surgery. Secondary endpoints are further efficacy and subject-oriented parameters within 90 days after surgery. The entire trial is planned for 54 months, with an enrolment of 1420 patients over 39 months by 14 national participating centres. DISCUSSION: As a highly standardised procedure on an exceeding, healthy and young homogenous study population and identical processes all over the world, elective orthognathic surgery as clean-contaminated procedure provides comparable intervention groups with balanced baseline characteristics, comparable surgical duration, even when performed within multiple centres. Therefore, evaluating antibiotic prophylaxis after orthognathic surgery will be of high scientific value representable for other surgical procedures. TRIAL REGISTRATION: DRKS-German Clinical Trials Register- DRKS00022838 ; EudraCT No. 2020-001397-30. Registered on 29 March 2021.
引用
- Ristow O, Hofele C, Münch P, et al. APOS-antibiotic prophylaxis for preventing infectious complications in orthognathic surgery: study protocol for a phase III, multicentre, randomised, controlled, double blinded, clinical trial with two parallel study arms. Trials. 2021. PMID: 34727951. doi:10.1186/s13063-021-05710-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。